SEC Filings | Allogene Therapeutics

Filing date	Description	Form	View
Dec 15, 2023	CORRESP	CORRESP	0001193125-23-296444.pdf 0001193125-23-296444.rtf 0001193125-23-296444.xls View HTML
Nov 21, 2023	UPLOAD	UPLOAD	0000000000-23-012789.pdf 0000000000-23-012789.rtf View HTML
Nov 02, 2023	Report of unscheduled material events or corporate event	8-K	0001737287-23-000089.pdf 0001737287-23-000089.rtf 0001737287-23-000089.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Nov 02, 2023	Quarterly report which provides a continuing view of a company's financial position	10-Q	0001737287-23-000091.pdf 0001737287-23-000091.rtf 0001737287-23-000091.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Nov 02, 2023	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	424B5	0001193125-23-269437.pdf 0001193125-23-269437.rtf 0001193125-23-269437.xls View HTML
Oct 25, 2023	An amendment to a SC 13D filing	SC 13D/A	0000078003-23-000104.pdf 0000078003-23-000104.rtf 0000078003-23-000104.xls View HTML
Oct 17, 2023	Amendment to a previously filed 8-K	8-K/A	0001737287-23-000083.pdf 0001737287-23-000083.rtf 0001737287-23-000083.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Oct 17, 2023	Statement of changes in beneficial ownership of securities	4	0001593968-23-001369.pdf 0001593968-23-001369.rtf 0001593968-23-001369.xls View HTML
Oct 16, 2023	Report of unscheduled material events or corporate event	8-K	0001737287-23-000079.pdf 0001737287-23-000079.rtf 0001737287-23-000079.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Oct 16, 2023	Initial filing by director officer or owner of more than ten percent	3	0001593968-23-001368.pdf 0001593968-23-001368.rtf 0001593968-23-001368.xls View HTML

Data provided by Kaleidoscope.